Preclinical Imaging (In-VIVO) Market Analysis & Forecast 2024-2030

Preclinical Imaging (In-VIVO) Market by Techniques ( MRI (Magnetic Resonance Imaging), PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography) Micro-CT (Micro Computed Tomography), Optical imaging and Magnetic particle (MPI)) by Application ( Oncology, Neurology, Cardiology, Inflammation, Infectious diseases, Cancer research, Functional and Anatomical Neuroimaging, Orthopedics, Cardiac imaging and Stroke models) by Industry Analysis, Volume, Share, Growth, Challenges, Trends, and Forecast 2024-2030, Regional Outlook ( North America, Europe, Asia-Pacific, Middle-East, Africa)

Report Code: PSMR- 540          Category: Medical Devices          Region :  Global         Report Format :                  

 Download Free Sample

 Table of Contents

Global Preclinical Imaging (In-VIVO) Market is expected to reach USD 1616.96 million by 2031 with CAGR of 4.9 % between 2025 and 2031

Preclinical imaging is medical process of visualization of living animals for purpose of research, such as new medical procedure and drug development. In vivo imaging has been described as bridging the gap between in vitro exploratory and in vivo clinical research, facilitating the direct and fast transfer of preclinical studies on animal models to clinical investigation in man. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes.  


Preclinical Imaging (In-VIVO) Market

In application aspect, vivo imaging is increasingly deployed across the drug development process, with applicability in target identification, compound optimization and pre-Phase I studies. In vivo imaging has been described as bridging the gap between in vitro exploratory and in vivo clinical research, facilitating the direct and fast transfer of preclinical studies on animal models to clinical investigation in man. The key diseases/therapeutic areas targeted with in vivo preclinical imaging by survey respondents were oncology/cancer (70% targeting). This was followed by inflammatory disease/autoimmune (36% targeting), neurology / CNS / neurodegeneration/ pain (32% targeting) and then cardiovascular (25% targeting)  


Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally. The most suitable modalities for small-animal in vivo imaging applications are based on nuclear medicine techniques (essentially, positron emission tomography [PET] and single photon emission computed tomography [SPECT]), optical imaging (OI), computed tomography (CT), magnetic resonance imaging (MRI), magnetic resonance spectroscopy imaging (MRSI), and ultrasound.  


Geographically, Preclinical Imaging (In-VIVO) Market categorised in North America, Europe, China, Japan, South East Asia, India and Rest of World. North America holds the highest sale volume of market. Increased in Pharmaceutical research, new development in biotechnology, government support for various research work and advancement in technology are the prime factor driving the Preclinical Imaging (In-VIVO) Market globally. Europe and Asia –Pacific market is expected to grow at higher CAGR in forecasted years. African market expected to grow at lower rate while Middle East and South American market is expected to show constant growth rate.  


Preclinical Imaging (In-VIVO) Market: Techniques Type

  • MRI (Magnetic Resonance Imaging)
  • PET (Positron Emission Tomography)
  • SPECT (Single Photon Emission Computed Tomography)
  • Micro-CT (Micro Computed Tomography)
  • Optical imaging and Magnetic particle (MPI)

Preclinical Imaging (In-VIVO) Market: Vessel Type

  • Oncology
  • Neurology
  • Cardiology
  • Inflammation
  • Infectious diseases
  • Cancer research
  • Functional and Anatomical Neuroimaging
  • Orthopedics
  • Cardiac imaging
  • Stroke models

Preclinical Imaging (In-VIVO) Market : Competitive Analysis

Report includes accurate analysis of key players with Market Value, Company profile, SWOT analysis. The Study consists of following key players in Preclinical Imaging (In-VIVO) Market:

  • PerkinElmer
  • Bruker Corporation
  • FUJIFILM Holdings
  • Mediso
  • MILabs B.V.
  • MR Solutions
  • Aspect Imaging
  • LI-COR Biosciences
  • Trifoil Imaging
  • Miltenyi Biotec

Geographical analysis of Preclinical Imaging (In-VIVO) Market:

  • North America
    • U.S.A
    • Canada
  • Europe
    • France
    • Germany
    • Spain
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South East Asia
  • Latin America
    • Brazil
  • Middle East and Africa

Global Preclinical Imaging (In-VIVO) Market Report delivers a comprehensive analysis of the following parameters:

  • Market Forecast for 2024-2030
  • Market growth drivers
  • Challenges and Opportunities
  • Emerging and Current market trends
  • Market player Capacity, Production, Revenue (Value)
  • Supply (Production), Consumption, Export, Import analysis
  • End user/application Analysis

Report Coverage

Parameters Details

Base Year

2024

Historical Data

2018-2023

Forecast Data

2024-2030

Base Year Value (2024)

USD 1156.83 million

Forecast Value (2031)

USD 1616.96 million

CAGR (2025-2030)

4.9 %

Regional Scope

North America, Europe, Asian Pacific, Latin America, Middle East and Africa, and ROW


Frequently Asked Questions (FAQ)


Preclinical Imaging (In-VIVO) Market was valued at around USD 1156.83 million in 2023 & estimated to reach USD 1616.96 million by 2030.




Preclinical Imaging (In-VIVO) Market is likely to grow at Compound Annual Growth Rate (CAGR) of 4.9% between 2024 to 2030.




Preclinical Imaging (In-VIVO) Market is dominated by the MRI (Magnetic Resonance Imaging) segment and the North America region holds the highest market share in 2023.



Some of the top key players in the Preclinical Imaging (In-VIVO) Market are PerkinElmer, Bruker Corporation, FUJIFILM Holdings, Mediso, MILabs B.V., MR Solutions, Aspect Imaging, LI-COR Biosciences, Trifoil Imaging, Miltenyi Biotec.




Primary driving factors for the growth of the Preclinical Imaging (In-VIVO) Market include Increased in Pharmaceutical research, new development in biotechnology, government support for various research work and advancement in technology.




Yes, the report includes COVID 19 impact on the market.



Purchase Options

    Cloud Access $2450

    Corporate User $3550

        Licence

    Enterprise Licence $4050

Inquire Before Buying

Please fill below details:






    ×
    Free Customization

    We are committed to offering 100 % free customization while purchasing.



      Access FREE Sample

      Receive a detailed insight into the Preclinical Imaging (In-VIVO) Market research study with our FREE sample report delivered straight to your email. The report covers major market factors such as Revenue, Forecast, Top companies insight, Regional analysis, Market trends & more.

       Download Free Sample




        ×